Veracyte VCYT Testing revenue — Other cost

Similar metrics at other companies

LIFOther — Total Cost of Revenue

$1.5M+39.3%

FLROther — Total Cost of Revenue

-$1M+92.3%

RNGOther — Total cost of revenues

$25.02M-8.5%

MTZ

MTZOther — Costs of revenue, excluding depreciation and amortization

$0—

RALTest and Measurement — Other non-operating expenses, net

$0+100%

TYLOther — Total cost of revenues

$8.91M+66.4%

Questions, answered.

What is Veracyte's testing revenue — other cost?

Veracyte (VCYT) reported testing revenue — other cost of $4.94M in Q1 2026.

How has Veracyte's testing revenue — other cost changed year-over-year?

Veracyte's testing revenue — other cost increased by 45.8% year-over-year, from $3.39M to $4.94M.

What is the long-term trend for Veracyte's testing revenue — other cost?

Over 3 years (2022 to 2025), Veracyte's testing revenue — other cost has grown at a 25.6% compound annual growth rate (CAGR), from $9.91M to $19.65M.

What does testing revenue — other cost mean?

This encompasses miscellaneous direct costs associated with the testing segment that do not fall into primary categories like labor or reagents. It is used to track ancillary operational expenses that impact the gross margin of the testing business.